Ligand · 8G9
8G9 · (1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
8G9, (1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide (C26 H45 N5 O5, 507.7 g/mol), in the MolNFT structures on…
- Component
- 8G9
- Formula
- C26 H45 N5 O5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
8G9 in 2 structures; the first of them:
- 7S6W · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI29 · 8G9 A401 · binds HIS41, MET49, TYR54, PHE140, LEU141, ASN142, GLY143, SER144 and 14 more
- 7S6W · Structure of the SARS-cov-2 main protease in complex with inhibitor MPI29 · 8G9 A401 · binds HIS41, MET49, TYR54, PHE140, LEU141, ASN142, GLY143, SER144 and 14 more
Residues it binds most
HIS 4, GLN 4, LEU 4, MET 4, SER 4, ARG 4, ASN 4, ASP 4, CYS 4, GLU 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.